Evaluation of microRNA‐10a and microRNA‐210 as Biomarkers in Sepsis Patients With Acute Kidney Injury
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in International Journal of Nephrology
- Vol. 2024 (1) , 1555811
Abstract
Background: Sepsis‐associated acute kidney injury (AKI) is a condition that increases in‐hospital mortality and the risk of progression to CKD. The current method of detecting AKI, which relies on increased serum creatinine levels or a decrease in urine output, has low sensitivity. Early diagnosis and appropriate intervention in AKI can lead to improved patient outcomes. Several low molecular weight proteins and microRNAs detected in AKI are considered early biomarkers of AKI, such as miR‐10a‐5p and miR‐210‐3p.Method: A cross‐sectional study was conducted among 62 participants, consisting of 26 sepsis patients with AKI, 26 sepsis patients without AKI, and 10 healthy controls. AKI was determined according to KDIGO criteria. MicroRNA expression was analyzed using reverse transcription quantitative polymerase chain reaction (RT‐qPCR). Statistical analysis was obtained using the Kruskal–Wallis test, Spearman’s correlation coefficient, and ROC curve analysis.Result: The median miR‐10a‐5p expression of the healthy controls versus sepsis with AKI versus sepsis without AKI groups was 10.38 (5.50–33.82) versus 10.32 (3.32–31.53) versus 9.76 (0.32–97.36), while the median miR‐210‐3p expression was 0.20 (0.03–0.41) versus 0.38 (0.04–1.24) versus 0.29 (0.06–1.67), respectively, with p = 0.721 for miR‐10a‐5p and p = 0.013 for miR‐210‐3 p. A significant increase in miR‐210‐3p expression was found in the sepsis with AKI compared to the healthy controls (p = 0.013) and sepsis without AKI (p = 0.034). miR‐210‐3p significantly correlated with creatinine and urea serum level (p < 0.05); miR‐10a‐5p did not have a significant correlation. The sensitivity and specificity of miR‐10a‐5p were 61.5% and 47.2%, and miR‐210‐3p were 84.6% and 63.9% for determining AKI.Conclusion: The study’s findings revealed a significant increase in miR‐210‐3p expression in sepsis patients with AKI, indicating its potential as a promising biomarker for determining AKI. This discovery demonstrates that the diagnostic performance of miR‐210‐3p surpasses that of miR‐10a‐5p, providing a more accurate biomarker for diagnosing AKI in sepsis patients.Keywords
Funding Information
- Universitas Brawijaya (7724/5/UN10.F08/PM/2023)
This publication has 24 references indexed in Scilit:
- MicroRNAs in septic acute kidney injuryBurns & Trauma, 2023
- MicroRNA expression profiling in acute kidney injuryTranslational Research, 2022
- Cellular and functional biomarkers of renal injury and diseaseCurrent Opinion in Toxicology, 2022
- Acute kidney injury in the critically ill: an updated review on pathophysiology and managementIntensive Care Medicine, 2021
- Sepsis-Associated Acute Kidney InjuryCritical Care Clinics, 2021
- miR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory FunctionMediators of Inflammation, 2020
- Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting diseaseScientific Reports, 2019
- microRNA biosensors: Opportunities and challenges among conventional and commercially available techniquesBiosensors and Bioelectronics, 2018
- The cellular response to hypoxia: tuning the system with microRNAsJournal of Clinical Investigation, 2010
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3Journal of Biological Chemistry, 2008